 Exclusive contents: images and/or videos
Lesions in small vessels remain a challenge for PCIs. As many as 36% of patients undergoing PCI have vessels < 2.50 mm. Several studies have shown that as the vessel size decreases (from 4.0 to 2.5 mm) the probability of having a restenosis increases. We describe the case of a 51-year old man with multiple cardiovascular risk factors, treated for a long lesion with a 99% stenosis in the mid-segment of the LAD the day after a PCI of a significant, hazy, proximal occlusion of the ostium of the RCA.
click here to reroll the summary
A patient with severe symptomatic mitral stenosis 22 years after surgical closure of an ostium secundum ASD had favourable characteristics for a percutaneous mitral commissurotomy. The inter-atrial septum puncture was guided by intracardiac echocardiography. The advancement of the transseptal catheter was hampered due to the thickness of the surgically-repaired septum. It became possible after predilatation of the ASD closure patch by the use of coronary angioplasty balloons over a 0.014” guidewire, previously guided into the left atrium through the transseptal puncture needle. Consequently, the mitral commissurotomy was successfully performed using the stepwise Inoue balloon technique.
click here to reroll the summary
This report features a very rare event during carotid angioplasty in a 68-year-old male patient. The procedure was successful using a Fibernet embolic protection device, a Boston Scientific Carotid Wallstent and a 5.0mm balloon post-stent dilatation. After removal of the Fibernet device using the retrieval catheter, a torn 20cm linear PTFE fibre was identified. The patient’s post-procedure angiography was unremarkable and he has been symptom free to 30 days. A microscopic analysis revealed that the fibre consisted of PTFE (polytetrafluoroethylene), a common biocompatible fluoropolymer used in the construction of catheters, guidewires, and other components employed in percutaneous transluminal angioplasty.
click here to reroll the summary
The presence of huge thrombi in coronary arteries during treatment of acute coronary syndromes is not uncommon in interventional cardiology and can lead to serious damage of the distal microcirculation compromising the immediate and long-term outcomes after percutaneous intervention. However, there is no consensus on the best strategy to approach this problem. We report a case of unstable angina, post MI, where a huge thrombus was detected in the presence of an open culprit artery. “Off label” use of intracoronary rt-PA, 5 days after the acute coronary event proved to be a safe and efficient therapeutic option to deal with this very complex scenario.
click here to reroll the summary
A 54-year old male presented with an acute anterior MI and was treated with primary PCI. Due to a tortuous mid LAD artery, stent deployment was not possible using a Stabilizer™ wire plus a Balance Middleweight™ ‘buddy’ wire. However, using a Hi-Torque Wiggle Wire™ plus a Stabilizer™ ‘buddy’ wire, a 2.75x30 Endeavor™ drug eluting stent was successfully deployed with a good angiographic result. We discuss techniques to assist stent delivery in tortuous or calcified coronary anatomy, and consider the role of the Hi-Torque Wiggle Wire™ as an aid to stent delivery in this setting.
click here to reroll the summary
Left coronary dominance due to the continuation of left anterior descending to form the posterior descending artery is a rare form of coronary anomaly observed in normal human hearts. We describe a patient presenting for coronary angiogram with this variant. A review of the literature and the clinical implications of this anomaly will be discussed.
click here to reroll the summary
Editorial
Letters to the Editor
EAPCI column
Clinical research
34
Contemporary treatment of patients with chronic total occlusion: critical appraisal of different state-of-the-art techniques and devices
García-García H, Kukreja N, Daemen J, Tanimoto S, van Mieghem CAG, Gonzalo N, van Weenen S, van der Ent M, Sianos G, de Feyter PJ, Serruys PW
EuroInterv.2007;3:188-196
35
Small coronary arteries treated with sirolimus-eluting stents: one-year results of the PORTO multicentre registry
Seabra-Gomes R, Eduardo Sousa J, Sousa A, Teles R, Pereira H, Farto Abreu P, Adao M, Leitão Marques A, Gama Ribeiro V, Mourao L, Santos R, Cyrne Carvalho H, the PORTuguese prospective non-randomised multicentre Outcomes Trial of sirolimus-eluting stent in small native coronary arteries (PORTO Trial) Investigators and Committees for
EuroInterv.2007;3:197-205
36
Two-year results of a durable polymer everolimus-eluting stent in de novo coronary artery stenosis (The SPIRIT FIRST Trial)
Beijk M, Neumann F-J, Wiemer M, Grube E, Haase J, Thuesen L, Hamm C, Veldhof S, Dorange C, Serruys PW, Piek J
EuroInterv.2007;3:206-212
37
Safety and efficacy of multiple, overlapping polymer-based paclitaxel-eluting stents
Dawkins K, Grube E, Guagliumi G, Banning A, Zmudka K, Colombo A, Thuesen L, Hauptmann K, Marco J, Wijns W, Popma J, Weissman N, Koglin J, Russell ME, on behalf of the TAXUS VI investigators
EuroInterv.2007;3:213-221
39
A randomised controlled trial of upstream administration of eptifibatide in patients presenting non-ST segment elevation acute coronary syndrome treated with an invasive strategy
Durand E, Hamm C, Macaya C, Georges J-L, Coste P, Wolf J, Slama M, Husted S, Mosseri M, Lafont A, for the Prospective RAndomised placebo Controlled trial to assess the role of GP IIb/IIIa blockade by integrilin in patients with troponin Increase and non persistent ST segment elevation acute Coronary syndromE study (PRACTICE) investigators
EuroInterv.2007;3:228-234
43
A novel ultra-thin bare metal stent (BMS): results from a worldwide registry
Blanchard D, Danzi G, Urban P, Moseri M, Juergens C, Guyon P, Nowak B, Tresukosol D, Suttorp M, Farshid A, Kornowski R, Garcia E, Yeend R, Nagai H, Paunovic D, on behalf of MATSURI investigators
EuroInterv.2007;3:249-255
Expert review
Experimental research
Technical report
Image in cardiology
50
Kartagener’s Syndrome
EuroInterv.2007;3:289
Issue 10 has been released thanks to the support of the following partners:
- Abbott Vascular Devices
- Biosensors
- Boston Scientific
- Cordis, a Johnson & Johnson company
- GE Healthcare
- Hexacath
- Invatec
- Medtronic
- Orbus Neich
- Terumo
- X Stent
|